Solutions. J. Indian Chem. Soc., 62, 507-512
(1985).
4. P. Gariglio, Useful for rupturing eukaryote cells in transcription studies FEBS Lett. 44, 330
(1974)
5. R.J. MacDonald, In the guanidine
Genet. Dev., 8(1), 55-62 (1998).
2. Coffer, P.G. et al., Protein kinase B (c-Akt): a
multifunctional mediator of phosphatidylinositol
3-kinase activation. Biochem. J., 335(1), 1-13
(1998).
3. Ng
the current European, Japanese and United States Pharmacopoeia (EP, 2.6.13.;
JP, 4.05 and USP, 62).
Sabouraud Dextrose Agar (SDA) is available with identical media formulation in different filling
the current European, Japanese and United States Pharmacopoeia (EP, 2.6.13.;
JP, 4.05 and USP, 62).
Sabouraud Dextrose Agar (SDA) is available with identical media formulation in different filling
the current European, Japanese and United States Pharmacopoeia (EP, 2.6.13.;
JP, 4.05 and USP, 62).
Sabouraud Dextrose Agar (SDA) is available with identical media formulation in different filling
al., Cell, 88, 277-285 (1997).
17. Dixelius, J. et al., Cancer Res., 62, 1944-1947
(2002).
18. Miosge, M. et al., FASEB J., 13, 1743-1750 (1999).
19. Dhanabal, M. et al., Biochem. Biophys. Res.
Biochem., 62(2), 436-448 (1974).
12. Isomaa, B., and Hagerstrand, H., ConA-mediated
Agglutination in Rat T-lymphocytes is Enhanced
by the Membrane-perturbing Agent CTAB. Cell
Mol. Biol., 32(5), 627-
the current European, Japanese and United States Pharmacopoeia (EP, 2.6.13.;
JP, 4.05 and USP, 62).
Sabouraud Dextrose Agar (SDA) w. Chloramphenicol is available with identical media formulation
Human IGF-II contains 67 amino acids and shares
similar structural features with IGF-I, including a 62%
sequence homology.7 In human plasma IGF-I and IGF-II
are associated with IGF-binding proteins,8,9
Human IGF-II contains 67 amino acids and shares similar
structural features with IGF-I, including a 62% sequence
homology. In human plasma, IGF-I and IGF-II are7
associated with IGF-binding proteins
the current European, Japanese and United States Pharmacopoeia (EP, 2.6.13.;
JP, 4.05 and USP, 62).
Sabouraud Dextrose Agar (SDA) w. Chloramphenicol is available with identical media formulation
the current European, Japanese and United States Pharmacopoeia (EP, 2.6.13.;
JP, 4.05 and USP, 62).
Sabouraud Dextrose Agar (SDA) w. Chloramphenicol is available with identical media formulation